| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/26/2007 | WO2007046548A1 Pyrazolo[1,5-a]pyrimidine compounds as cannabinoid receptor antagonists |
| 04/26/2007 | WO2007046392A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/26/2007 | WO2007045987A1 New anti-malaria derivatives of 4-aminoquinoline |
| 04/26/2007 | WO2007045392A1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | WO2007045096A1 Oligoheteroaromatic luminiscent assemblies as high-affinity dna sequence-directed ligands |
| 04/26/2007 | WO2007045060A1 Pharmaceutical compositions containing erythrine mulungu derivatives and processes for their production |
| 04/26/2007 | WO2007027233A3 Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid |
| 04/26/2007 | WO2007023382A3 Pyrimidine amino pyrazole compounds, potent kinase inhibitors |
| 04/26/2007 | WO2006099075A3 Certain substituted amides, method of making, and method of use thereof |
| 04/26/2007 | WO2006072785A3 Base stable ionic liquids |
| 04/26/2007 | WO2006053121A3 Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity |
| 04/26/2007 | WO2006029075A8 Fibrate compounds having ppar agonist activity |
| 04/26/2007 | WO2005012304A3 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 04/26/2007 | US20070093512 4-Phenylaminopyrido[4,3-d]pyrimidines 6-heteroaryl-substituted, in which the heteroaryl is substituted with a sulfonylethylamino-, thio- or oxy- group; protein tyrosine kinase inhibitors, used especially to treat various malignancies |
| 04/26/2007 | US20070093501 Urea derivative, process for producing the same, and use |
| 04/26/2007 | US20070093496 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors |
| 04/26/2007 | US20070093494 e.g. 8-(5-bromoquinoxalin-6-yl)-5-oxo-2,3,5,6,7,8-hexahydroimidazo[1,2-a]pyrimidine-7-carboxylic acid; beta -adrenoreceptor antagonists; ocular hypotensive agents; glaucoma |
| 04/26/2007 | US20070093492 Pyrrolidine derivatives |
| 04/26/2007 | US20070093491 Novel condensed n-pyrazinyl-sulphonamides and their use in the treament of chemokine mediated diseases |
| 04/26/2007 | US20070093490 protein kinase inhibitors such as (3-phenylimidazo[1,2b]pyridazin-6-yl)-(3-pyrrolidin-1-ylpropyl)amine, used in the treatment or prophylaxis of disorders which are associated with overexpression or mutation of activin receptor-like kinases |
| 04/26/2007 | US20070093463 Radiation enhancement agent for X-ray radiation therapy and boron neutron-capture therapy |
| 04/26/2007 | US20070093391 Weed control |
| 04/26/2007 | US20070093390 Synergistically acting herbicidal mixtures |
| 04/26/2007 | US20070093379 Metal catalysts (preferably manganese-containing catalysts) complexed with selected macropolycyclic rigid ligands, preferably cross-bridged macropolycyclic ligands; useful for oxidative synthetic chemistry processes, bleaching of pulp and paper products |
| 04/26/2007 | US20070092867 Application using non-covalent bond between a cucurbituril derivative and a ligand |
| 04/26/2007 | US20070092441 Fluoridation method |
| 04/26/2007 | CA2628577A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 04/26/2007 | CA2626742A1 Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators |
| 04/26/2007 | CA2625442A1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | CA2624492A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/25/2007 | EP1777227A1 Novel hole transporting material and solid electrolyte to be applied in a photovoltaic device |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1776368A1 Inhibitors of hcv replication |
| 04/25/2007 | EP1776367A1 Synthesis of 6,7-dihydro-5h-imidazoý1,2-a¨imidazole-3-sulfonic acid amides |
| 04/25/2007 | EP1776366A1 Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors |
| 04/25/2007 | EP1776364A2 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin |
| 04/25/2007 | EP1776360A1 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nachr ligands for the treatment of cns diseases. |
| 04/25/2007 | EP1776160A1 Novel serotonin receptor ligands and their uses thereof |
| 04/25/2007 | EP1699795B1 Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalklymine]-pyrimido[1,2a]pyrimidin-6-one derivatives |
| 04/25/2007 | EP1697371B1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 04/25/2007 | EP1697370B1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 04/25/2007 | EP1436297B1 Photoactivable nitrogen bases |
| 04/25/2007 | EP1401449B1 Tetracyclic compounds as pde5-inhibitors |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1200824B1 Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives |
| 04/25/2007 | CN1953981A Method for producing a solution of pure triethylenediamine (TEDA) |
| 04/25/2007 | CN1953980A Triazolopyrimidine compounds and their use for controlling pathogenic fungi |
| 04/25/2007 | CN1953963A Process for producing cyclic N-hydroxyimide compound |
| 04/25/2007 | CN1953747A Diphenyl-indol-2-on compounds and their use in the treatment of cancer |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |
| 04/25/2007 | CN1951917A Pyridinone derivatives for treatment of atherosclerosis |
| 04/25/2007 | CN1312154C Purine derivatives as kinase inhibitors |
| 04/25/2007 | CN1312153C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 04/25/2007 | CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 04/25/2007 | CN1312136C Triazole derivatives as tachykinin receptor antagonists |
| 04/25/2007 | CN1312135C Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents |
| 04/25/2007 | CN1312131C Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent |
| 04/25/2007 | CN1312093C Anti-oxidation single component aromatic hydrocarbon solvent used in copper phthalocyanine synthesis |
| 04/25/2007 | CN1312086C Process for producing cyclic compound |
| 04/24/2007 | USRE39590 3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione; useful for general or pre-emergent or post-emergent control of undesired plant species and defoliants at very low concentrations |
| 04/24/2007 | US7208630 Having a chimeric structure based, in part, on two naturally occurring Hsp90 inhibitors: radicicol ("RDC") and geldanamycin ("GDA"). |
| 04/24/2007 | US7208596 Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof |
| 04/24/2007 | US7208493 Vasculostatic agents and methods of use thereof |
| 04/24/2007 | US7208492 Topoisomerase-targeting agents |
| 04/24/2007 | US7208490 Having useful antibacterial activity against a wide range of human and veterinary pathogens; for therapy of microbial infections in mammals |
| 04/24/2007 | CA2166811C Tricyclic inhibitors of the gpiibiiia receptor |
| 04/19/2007 | WO2007044933A1 Hepatitis c virus inhibitors |
| 04/19/2007 | WO2007044885A2 Piperidine derivatives and methods of use |
| 04/19/2007 | WO2007044804A2 Piperidine derivatives and methods of use |
| 04/19/2007 | WO2007044449A2 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/19/2007 | WO2007044426A2 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/19/2007 | WO2007044420A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors for the treatment of cancer |
| 04/19/2007 | WO2007044410A1 Pyrazolo [1,5-a] pyrimidines as protein kinase inhibitors |
| 04/19/2007 | WO2007044407A2 Pyrazolo (1 , 5a) pyrimidines as protein kinase inhibitors |
| 04/19/2007 | WO2007044401A2 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/19/2007 | WO2007043835A1 Fab i inhibitor and process for preparing same |
| 04/19/2007 | WO2007042784A2 Pyrimidin-4-yl-3, 4-dihydr0-2h- pyrrolo [1, 2a] pyrazin-1-one compounds |
| 04/19/2007 | WO2007042506A1 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging |
| 04/19/2007 | WO2007042421A1 Imidazo benzodiazepine derivatives |
| 04/19/2007 | WO2007042299A1 Pyrrolopyrimidine derivatives as syk inhibitors |
| 04/19/2007 | WO2007042298A1 Pyrrolopyrimidine derivatives as syk inhibitors |
| 04/19/2007 | WO2007042250A1 Prolinamide derivatives as sodium channel modulators |
| 04/19/2007 | WO2007042240A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |
| 04/19/2007 | WO2006116157A3 Dipeptidyl peptidase-iv inhibitors |
| 04/19/2007 | WO2006101217A3 Luminous compound containing lanthanide ion |
| 04/19/2007 | WO2006076284A3 AMINO-IMIDAZOLONES FOR THE INHIBITION OF ß-SECRETASE |
| 04/19/2007 | WO2006033005A8 Thrombopoietin receptor agonists |
| 04/19/2007 | US20070088158 Boron complexation strategy for use in manipulating 1-acyldipyrromethanes |
| 04/19/2007 | US20070088041 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals |
| 04/19/2007 | US20070088040 ethyl 1-(2,4-dimethoxybenzyl)-7-(2-(S)-hydroxymethyl-pyrrolidin-1-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylate; 7-(2-aminomethylpyrrolidin-1-yl)-1-(2,4-dimethoxybenzyl)-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-caboxylic acid; treating quinolone-resistant bacterial infections in a mammal |
| 04/19/2007 | US20070088039 Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function |
| 04/19/2007 | US20070088038 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions |
| 04/19/2007 | US20070088037 Cancer and fibrotic diseases |
| 04/19/2007 | US20070088036 1-[2-(4-chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-4-(4-chloro-phenyl)-piperidine-4-carbonitrile; -[2-(4-chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-4-(4-chloro-phenyl)-piperidine-4-carboxylic acid methyl ester; deposited on a stent or stent-graft device |
| 04/19/2007 | US20070088035 Crystalline forms of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester |
| 04/19/2007 | US20070088026 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi |
| 04/19/2007 | US20070088022 Tetrahydroquinolines, synthesis thereof, and intermediates thereto |
| 04/19/2007 | CA2627623A1 Methods for inhibiting protein kinases |
| 04/19/2007 | CA2625962A1 Fab i inhibitor and process for preparing same |
| 04/19/2007 | CA2625763A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |